Chimeric Therapeutics Limited (CHM)
Market Open
ASX ASX Primary 11.03M Market Cap
- P/E Ratio
- Div Yield
203,023 Volume
0 Eps
Want to track CHM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
CHM Earnings Reports FAQ
What is the earnings per share (EPS) for CHM?
The current EPS is 0.
What is the company's earnings growth rate?
Chimeric Therapeutics Limited has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Chimeric Therapeutics Limited has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Chimeric Therapeutics Limited are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for CHM at this time, as Chimeric Therapeutics Limited has no recent EPS data to calculate it.
